SENS
Senseonics Holdings, Inc.6.62
-0.17-2.5%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
270.48MP/E (TTM)
-Basic EPS (TTM)
-1.54Dividend Yield
0%Recent Filings
10-Q
8-K
8-K
Senseonics enacts 1-for-20 split
Senseonics Holdings executed a 1-for-20 reverse stock split, effective October 17, 2025, consolidating every 20 shares into one while slashing authorized common stock from 1,400,000,000 to 70,000,000 shares. This move, filed with Delaware on October 16, adjusts options, RSUs, and warrants proportionally, with cash for fractional shares to preserve ownership percentages. Trading resumes adjusted on NYSE American October 20 under SENS. No impact on par value.
8-K
Q3 revenue jumps 91%
8-K
Stockholders approve reverse split
Senseonics Holdings stockholders approved a flexible reverse stock split on September 29, 2025, allowing the board to implement a 1-for-10 to 1-for-20 ratio anytime before September 29, 2026, with a matching cut in authorized shares. The vote passed with 285.6 million shares in favor versus 178.2 million against and 5.0 million abstentions. This move aims to boost share price and maintain NYSE American compliance. Board discretion shapes the timing.
BBNX
Beta Bionics, Inc.
29.63-0.09
DXCM
DexCom, Inc.
66.37+0.64
GCTK
GlucoTrack, Inc.
5.18+0.03
ICCM
IceCure Medical Ltd.
0.63-0.01
INSP
Inspire Medical Systems, Inc.
115.51-3.75
MDT
Medtronic plc.
97.72-0.85
MODD
Modular Medical, Inc.
0.34-0.03
NMTC
NeuroOne Medical Technologies C
0.71+0.05
PODD
Insulet Corporation
288.73-2.78
TMDX
TransMedics Group, Inc.
125.04+1.89